DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Davis MR, Donnelley MA, Thompson GR.
Ibrexafungerp: a novel oral glucan synthase inhibitor.
Med Mycol 2019; (e-pub ahead of print)
DOI: 10.1093/mmy/myz083.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.